Platform
Features
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Stage
Employees
Links
Kenneth Galbraith
53 members
20 members
6 members
14 members
9 members
View all
Abzena
1 follower
Gilead Sciences
119 followers
Lonza
26 followers
BeiGene
18 followers
PartnerOne
Stemline Therapeutics
3 followers
Roche
220 followers
Akebia Therapeutics
Aldevron
Kiniksa Pharmaceuticals
CGI
132 followers
Discover companies